Ketamine-Augmented Hypnotherapy

Ketamine shows antidepressant effects by blocking NMDA receptors and promoting neuroplasticity. Combining it with psychotherapy may enhance treatment for depression, trauma, addiction, and other serious conditions by temporarily disrupting rigid thought patterns and enabling new cognitive and emotional connections. This approach remains experimental and is recommended only after standard treatments fail. The article outlines the neurobiological basis of altered states of consciousness and presents initial clinical experience with ketamine-augmented hypnotherapy (KAHT) as one specific method of ketamine-assisted psychotherapy.

Study at a glance

Abstract

The therapeutic use of ketamine and other psychoactive substances in psychiatry is attracting growing research interest, particularly in treatment-resistant depression and related conditions refractory to conventional care. Ketamine exerts direct pharmacological antidepressant effects through NMDA receptor antagonism and downstream neuroplastic mechanisms; its combination with structured psychotherapy represents a promising augmentation strategy, though one that remains largely experimental and is currently recommended only for patients who have not responded to established treatments. By transiently attenuating self-referential processing and the dominance of habitual evaluative frameworks, psychoactive substances may enable new affective and cognitive connections — creating a window of opportunity for therapeutic change that is difficult to achieve through endogenous means alone. This potential appears transdiagnostic, extending beyond depression to trauma-related disorders, substance dependence, and other serious psychiatric conditions. The present article describes the theoretical and neurobiological foundations of altered states of consciousness relevant to this work, and presents preliminary clinical experience with ketamine-augmented hypnotherapy (KAHT) as a specific implementation of ketamine-assisted psychotherapy.